As of 2026-05-24, the EV/EBITDA ratio of Bliss GVS Pharma Ltd (BLISSGVS.NS) is 12.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLISSGVS.NS's latest enterprise value is 30,322.83 mil INR. BLISSGVS.NS's TTM EBITDA according to its financial statements is 2,375.67 mil INR. Dividing these 2 quantities gives us the above BLISSGVS.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 11.7x | 8.9x |
| Forward P/E multiples | 8.3x - 10.7x | 9.4x |
| Fair Price | 166.42 - 320.66 | 248.94 |
| Upside | -44.6% - 6.8% | -17.1% |
| Date | EV/EBITDA |
| 2026-05-22 | 12.76 |
| 2026-05-21 | 12.53 |
| 2026-05-20 | 12.26 |
| 2026-05-19 | 11.99 |
| 2026-05-18 | 12.35 |
| 2026-05-15 | 11.71 |
| 2026-05-14 | 12.17 |
| 2026-05-13 | 11.86 |
| 2026-05-12 | 11.68 |
| 2026-05-11 | 11.55 |
| 2026-05-08 | 11.41 |
| 2026-05-07 | 11.50 |
| 2026-05-06 | 11.32 |
| 2026-05-05 | 11.39 |
| 2026-05-04 | 11.59 |
| 2026-04-30 | 11.70 |
| 2026-04-29 | 11.38 |
| 2026-04-28 | 11.50 |
| 2026-04-27 | 11.53 |
| 2026-04-24 | 11.12 |
| 2026-04-23 | 11.33 |
| 2026-04-22 | 11.58 |
| 2026-04-21 | 10.97 |
| 2026-04-20 | 10.72 |
| 2026-04-17 | 10.90 |
| 2026-04-16 | 10.95 |
| 2026-04-15 | 10.84 |
| 2026-04-13 | 11.01 |
| 2026-04-10 | 10.92 |
| 2026-04-09 | 10.70 |
| 2026-04-08 | 10.68 |
| 2026-04-07 | 9.94 |
| 2026-04-06 | 9.92 |
| 2026-04-02 | 9.84 |
| 2026-04-01 | 9.62 |
| 2026-03-30 | 9.03 |
| 2026-03-27 | 9.10 |
| 2026-03-25 | 9.36 |
| 2026-03-24 | 8.59 |
| 2026-03-23 | 8.03 |
| 2026-03-20 | 8.74 |
| 2026-03-19 | 8.68 |
| 2026-03-18 | 8.98 |
| 2026-03-17 | 8.70 |
| 2026-03-16 | 8.44 |
| 2026-03-13 | 8.43 |
| 2026-03-12 | 8.77 |
| 2026-03-11 | 9.02 |
| 2026-03-10 | 9.30 |
| 2026-03-09 | 8.50 |